Paclitaxel-loaded chitosan nanosuspensions show high drug loading, positive surface charge, strong mucin adhesion, and sustained release; in mice, the nanosuspension reduced tumor volume and increased necrotic areas compared with paclitaxel/chitosan blends [9]. This evidence concerns the gene MUC5AC and neoplasm.